SMT Raises Series B

Seattle Medical Technologies, a Seattle-based medical device company focused on diabetes, has called down $21 million of a $35 million Series B round, according to a regulatory filing. Canaan Partners and Skyline Venture Partners were joined by return backers Frazier Healthcare Ventures and Three Arch Partners. SMT was founded by serial medical entrepreneur Clif Alferness.